4Tech Brings Regulatory Expertise In-House
This article was originally published in Clinica
Transcatheter heart valve repair specialist 4Tech Inc. has appointed Paul Cornelison vice-president of regulatory affairs, quality assurance & clinical affairs. Cornelison has over 25 years’ experience in medtech-related regulatory and clinical affairs. More recently, prior to joining 4Tech, he had worked in a couple of transcatheter mitral valve repair companies: CardiAQ Valve Technologies Inc., which was acquired by Edwards Lifesciences in July 2015, and Cardiac Dimensions Inc, one of the earliest percutaneous mitral valve repair companies. Cornelison joins Galway, Ireland-based 4Tech just after the firm raised $29m in a series B financing round to help complete a feasibility study of its TriCinch transcatheter tricuspid valve repair system. The study results will be used to support approval to CE mark the device, said to be the only one fully focused on the tricuspid valve.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.